ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 134 filers reported holding ANAPTYSBIO INC in Q2 2024. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $665,694 | +405.2% | 26,564 | +354.0% | 0.00% | – |
Q1 2024 | $131,764 | +22.5% | 5,851 | +16.5% | 0.00% | – |
Q4 2023 | $107,550 | -60.7% | 5,021 | -67.1% | 0.00% | – |
Q3 2023 | $273,692 | -42.6% | 15,239 | -35.0% | 0.00% | – |
Q2 2023 | $476,566 | +32.9% | 23,430 | +42.2% | 0.00% | – |
Q1 2023 | $358,605 | +2658.5% | 16,480 | +2963.2% | 0.00% | – |
Q3 2022 | $13,000 | -40.9% | 538 | -50.9% | 0.00% | – |
Q2 2022 | $22,000 | -95.7% | 1,096 | -94.7% | 0.00% | – |
Q1 2022 | $514,000 | -44.5% | 20,790 | -22.0% | 0.00% | – |
Q4 2021 | $926,000 | -46.6% | 26,649 | -58.4% | 0.00% | – |
Q3 2021 | $1,735,000 | -16.1% | 63,984 | -19.7% | 0.00% | – |
Q2 2021 | $2,067,000 | +60.9% | 79,701 | +33.7% | 0.00% | – |
Q1 2021 | $1,285,000 | +48.0% | 59,624 | +47.6% | 0.00% | – |
Q4 2020 | $868,000 | +287.5% | 40,402 | +165.9% | 0.00% | – |
Q3 2020 | $224,000 | -47.5% | 15,196 | -20.5% | 0.00% | – |
Q2 2020 | $427,000 | +104.3% | 19,123 | +29.4% | 0.00% | – |
Q1 2020 | $209,000 | -49.5% | 14,777 | -87.0% | 0.00% | – |
Q4 2019 | $414,000 | -66.4% | 113,676 | +223.4% | 0.00% | – |
Q3 2019 | $1,231,000 | -33.3% | 35,153 | +7.5% | 0.00% | -100.0% |
Q2 2019 | $1,845,000 | -91.0% | 32,702 | -88.3% | 0.00% | -83.3% |
Q1 2019 | $20,495,000 | +15.6% | 280,570 | +0.9% | 0.01% | 0.0% |
Q4 2018 | $17,736,000 | -40.7% | 278,015 | -7.2% | 0.01% | -25.0% |
Q3 2018 | $29,904,000 | +1048.4% | 299,740 | +717.6% | 0.01% | +700.0% |
Q2 2018 | $2,604,000 | -31.1% | 36,662 | +1.0% | 0.00% | 0.0% |
Q1 2018 | $3,777,000 | +59.0% | 36,294 | +53.8% | 0.00% | 0.0% |
Q4 2017 | $2,376,000 | +828.1% | 23,593 | +222.0% | 0.00% | – |
Q3 2017 | $256,000 | +181.3% | 7,326 | +92.3% | 0.00% | – |
Q2 2017 | $91,000 | +2933.3% | 3,810 | +3710.0% | 0.00% | – |
Q1 2017 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $53,362,000 | 8.10% |
EcoR1 Capital, LLC | 7,521,024 | $152,677,000 | 5.27% |
GREAT POINT PARTNERS LLC | 453,118 | $9,198,000 | 2.21% |
Soleus Capital Management, L.P. | 643,575 | $13,065,000 | 2.04% |
Frazier Life Sciences Management, L.P. | 899,700 | $18,264,000 | 1.72% |
Boxer Capital, LLC | 1,300,000 | $26,390,000 | 1.67% |
Deep Track Capital, LP | 672,569 | $13,653,000 | 0.90% |
Palo Alto Investors LP | 431,024 | $8,750,000 | 0.76% |
TCG Crossover Management, LLC | 58,515 | $1,188,000 | 0.50% |
HighVista Strategies LLC | 33,103 | $672,000 | 0.41% |